Peter Schwandt

Summary

Country: Germany

Publications

  1. ncbi Sustained lifestyle advice and cardiovascular risk factors in 687 biological child-parent pairs: the PEP Family Heart Study
    Peter Schwandt
    Arteriosklerose Präventions Institut München Nürnberg, Wilbrechtstr 95, D 81477 München, Germany
    Atherosclerosis 219:937-45. 2011
  2. ncbi [Disordered lipid metabolism--current diagnostics]
    P Schwandt
    ,
    MMW Fortschr Med 145:26-7. 2003
  3. ncbi First reference curves of waist circumference for German children in comparison to international values: the PEP Family Heart Study
    Peter Schwandt
    Arteriosklerose Präventions Institut, Munich Nuremberg, Germany
    World J Pediatr 4:259-66. 2008
  4. ncbi [Lipid metabolism diseases]
    Peter Schwandt
    , Wilbrechtstr. 95,
    Med Monatsschr Pharm 26:368-72; quiz 373-4. 2003
  5. ncbi Cardiovascular risk screening in school children predicts risk in parents
    Peter Schwandt
    Arteriosklerose Praeventions Institut and Ludwig Maximilians University Munich, Germany
    Atherosclerosis 205:626-31. 2009
  6. ncbi [Secondary prevention of cardiovascular diseases. What do you recommend to your patients after myocardial infarct?]
    P Schwandt
    Arteriosklerose Präventions Institut, Munchen
    MMW Fortschr Med 144:27-8. 2002
  7. ncbi Global cardiovascular risk in children and their families: the Prevention Education Program (PEP), Nürnberg
    P Schwandt
    Medical Department, University of Munich, Arteriosklerose Präventions Institut, Wilbrechtstr 95, 81477 München, Germany
    Nutr Metab Cardiovasc Dis 11:35-9. 2001
  8. ncbi Ethnic disparities of the metabolic syndrome in population-based samples of german and Iranian adolescents
    Peter Schwandt
    Arteriosklerose Praeventions Institut, Munich Nuremberg, Germany
    Metab Syndr Relat Disord 8:189-92. 2010
  9. ncbi Anthropometric screening for silent cardiovascular risk factors in adolescents: The PEP Family Heart Study
    Peter Schwandt
    Arteriosklerose Praeventions Institut, Munich Nuremberg, Germany
    Atherosclerosis 211:667-71. 2010
  10. ncbi Lifestyle and cardiovascular risk factors in 2001 child-parent pairs: the PEP Family Heart Study
    Peter Schwandt
    Arteriosklerose Praeventions Institut, Wilbrechhtstr 95, Munich, Nuernberg, Germany
    Atherosclerosis 213:642-8. 2010

Collaborators

Detail Information

Publications28

  1. ncbi Sustained lifestyle advice and cardiovascular risk factors in 687 biological child-parent pairs: the PEP Family Heart Study
    Peter Schwandt
    Arteriosklerose Präventions Institut München Nürnberg, Wilbrechtstr 95, D 81477 München, Germany
    Atherosclerosis 219:937-45. 2011
    ..We examined whether associations between improved cardiovascular risk factors and lifestyle changes persist over 1 year in a real life setting...
  2. ncbi [Disordered lipid metabolism--current diagnostics]
    P Schwandt
    ,
    MMW Fortschr Med 145:26-7. 2003
  3. ncbi First reference curves of waist circumference for German children in comparison to international values: the PEP Family Heart Study
    Peter Schwandt
    Arteriosklerose Präventions Institut, Munich Nuremberg, Germany
    World J Pediatr 4:259-66. 2008
    ..Considering the lack of reference values in Germany, we developed age- and gender-specific WC smoothed reference curves in German children, and compared them with reference curves obtained from different countries...
  4. ncbi [Lipid metabolism diseases]
    Peter Schwandt
    , Wilbrechtstr. 95,
    Med Monatsschr Pharm 26:368-72; quiz 373-4. 2003
  5. ncbi Cardiovascular risk screening in school children predicts risk in parents
    Peter Schwandt
    Arteriosklerose Praeventions Institut and Ludwig Maximilians University Munich, Germany
    Atherosclerosis 205:626-31. 2009
    ..We examined whether cardiovascular risk factors in children predicted the risk of their parents...
  6. ncbi [Secondary prevention of cardiovascular diseases. What do you recommend to your patients after myocardial infarct?]
    P Schwandt
    Arteriosklerose Präventions Institut, Munchen
    MMW Fortschr Med 144:27-8. 2002
  7. ncbi Global cardiovascular risk in children and their families: the Prevention Education Program (PEP), Nürnberg
    P Schwandt
    Medical Department, University of Munich, Arteriosklerose Präventions Institut, Wilbrechtstr 95, 81477 München, Germany
    Nutr Metab Cardiovasc Dis 11:35-9. 2001
    ..The second aim of the PEP is to test the hypothesis that the individual risk can be changed by family lifestyle modifications...
  8. ncbi Ethnic disparities of the metabolic syndrome in population-based samples of german and Iranian adolescents
    Peter Schwandt
    Arteriosklerose Praeventions Institut, Munich Nuremberg, Germany
    Metab Syndr Relat Disord 8:189-92. 2010
    ..Therefore, we compared the prevalence of the metabolic syndrome and its components in two large representative samples of adolescents in Germany and Iran...
  9. ncbi Anthropometric screening for silent cardiovascular risk factors in adolescents: The PEP Family Heart Study
    Peter Schwandt
    Arteriosklerose Praeventions Institut, Munich Nuremberg, Germany
    Atherosclerosis 211:667-71. 2010
    ..Therefore, we examined six simple anthropometric measures for their utility in screening adolescents for seven silent CVD risk factors...
  10. ncbi Lifestyle and cardiovascular risk factors in 2001 child-parent pairs: the PEP Family Heart Study
    Peter Schwandt
    Arteriosklerose Praeventions Institut, Wilbrechhtstr 95, Munich, Nuernberg, Germany
    Atherosclerosis 213:642-8. 2010
    ..Since individual risk factor profiles are easily predicted within families, we examined whether CVD risk factors are affected by lifestyle factors in these families...
  11. ncbi Achieving lipid goals in Europe: how large is the treatment gap?
    Peter Schwandt
    Institute for Arteriosclerosis Prevention, Wilbrechtstr 95, D 81477 Munich, Germany
    Expert Rev Cardiovasc Ther 2:431-49. 2004
    ....
  12. ncbi BMI and hyperinsulinemia in children
    Michael Vogeser
    Institute of Clinical Chemistry, University of Munich, Marchioninistr 15, D 81377 Munich, Germany
    Clin Biochem 42:1427-30. 2009
    ..Overweight is associated with hyperinsulinemia in adults and children. The aim of our study was to test if body mass index (BMI) alone or in combination with waist circumference (WC) predicts hyperinsulinemia in individual children...
  13. ncbi Nutrition, antioxidants, and risk factor profile of nonsmokers, passive smokers and smokers of the Prevention Education Program (PEP) in Nuremberg, Germany
    Marieluise Tröbs
    Analytisch Biologisches Forschungslabor, Goethestrasse 20, Munich, 80336, Germany
    Prev Med 34:600-7. 2002
    ..We investigated both by questionnaires and biochemical analyses whether smokers influence the dietary habits of nonsmokers living in the same household...
  14. ncbi [Prevention of arteriosclerosis must start in childhood. The Nuremberg Prevention-Education Program (PEP)]
    G M Haas
    ,
    MMW Fortschr Med 145:34, 36. 2003
  15. ncbi [The Nurnberg Prevention and Education Program: healthy nutrition can be learned]
    Peter Schwandt
    Pflege Z 55:807-8. 2002
  16. ncbi Lifestyle, Cardiovascular Drugs and Risk Factors in Younger and Elder Adults: The PEP Family Heart Study
    Peter Schwandt
    Arteriosklerose Praeventions Institut, Munich Nuremberg, Germany
    Int J Prev Med 1:56-61. 2010
    ..This study aimed to compare cardiovascular disease (CVD) risk factors, lifestyle habits and pharmacological treatment in two groups of elder adults with 20 years difference in their mean age...
  17. ncbi Metabolic risk factors, leisure time physical activity, and nutrition in german children and adolescents
    Gerda Maria Haas
    Atherosclerosis Prevention Institute, Munich Nuremberg, 81477 Munich, Germany
    Cholesterol 2012:370850. 2012
    ..3 mmol/L) was 1.7-fold (CI 1.0-2.6) higher in youth with high (≥33%) saturated fat consumption. A low polyunsaturated/saturated fat ratio (P/S ratio) was significantly associated with fasting hyperglycemia (OR 1.4; 95% CI 1.0-1.2)...
  18. ncbi Trends of Components of the Metabolic Syndrome in German First Graders Throughout 10 Years: The PEP Family Heart Study
    Gerda Maria Haas
    Arteriosklerose Präventions Institut, 81477 München, Germany
    Cholesterol 2012:231962. 2012
    ..Whereas the prevalence of abdominal adiposity was stable at baseline and after 10 years (-1% in boys and +2% in girls), the prevalence of hypertension, hypertriglyceridemia, low HDL-C, and glucose was very low without any trend...
  19. ncbi Effects of direct adsorption of lipoproteins apheresis on lipoproteins, low-density lipoprotein subtypes, and hemorheology in hypercholesterolemic patients with coronary artery disease
    Carsten Otto
    Medical Department II, Klinikum Grosshadern, University of Munich, Munich, Germany
    Ther Apher 6:130-5. 2002
    ..08 < p < 0.14). In conclusion, DALI apheresis not only reduces LDL cholesterol but also induced a significant reduction of cholesterol in all LDL subfractions and improved various hemorheological parameters...
  20. ncbi Prevalence of Cardiovascular Disease Risk Factors in Migrants Participating in the PEP Family Heart Study, Nuremberg
    Gerda Maria Haas
    Arteriosklerose Praeventions Institute, Munich Nuremberg, Germany
    Int J Prev Med 1:19-28. 2010
    ....
  21. ncbi Effect of atorvastatin on lipid parameters, LDL subtype distribution, hemorrheological parameters and adhesion molecule concentrations in patients with hypertriglyceridemia
    K Empen
    Medical Department II, Ludwig-Maximilians-University, Munich, Germany
    Nutr Metab Cardiovasc Dis 13:87-92. 2003
    ....
  22. ncbi Efficacy of different low-density lipoprotein apheresis methods
    K G Parhofer
    Medical Department II, Klinikum Grosshadern, Ludwig Maximilians University, Munich, Germany
    Ther Apher 4:382-5. 2000
    ..Therefore, the decision of which system should be used in a given patient must be individualized taking the pre-apheresis LDL concentration, concomitant pharmacotherapy, and fibrinogen concentration into account...
  23. ncbi Influence of atorvastatin versus simvastatin on fibrinogen and other hemorheological parameters in patients with severe hypercholesterolemia treated with regular low-density lipoprotein immunoadsorption apheresis
    C Otto
    Medical Department II, Klinikum Grosshadern, University of Munich, Germany
    Ther Apher 4:244-8. 2000
    ..Therefore, with respect to hemorheology, we conclude that atorvastatin should not be withheld from hypercholesterolemic patients regularly treated with LDL immunoadsorption...
  24. ncbi Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia
    H C Geiss
    Department of Internal Medicine II, Klinikum Grosshadern, University of Munich, Germany
    Exp Clin Endocrinol Diabetes 110:182-7. 2002
    ..However, the relative reduction of individual LDL-subtypes differed between both groups. This suggests that the effect of simvastatin on LDL-subtype distribution depends on the type of underlying hyperlipoproteinemia...
  25. ncbi Atorvastatin improves postprandial lipoprotein metabolism in normolipidemlic subjects
    K G Parhofer
    Department of Internal Medicine II, Klinikum Grosshadern, Ludwig Maximilians University, Munich, Germany
    J Clin Endocrinol Metab 85:4224-30. 2000
    ....
  26. ncbi Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia
    R J Frost
    Department of Internal Medicine II, Klinikum Grosshadern, Ludwig-Maximilians University, Munich, Germany
    Am J Cardiol 87:44-8. 2001
    ..We conclude that atorvastatin and fenofibrate can improve lipoprotein metabolism in type 2 diabetes. However, the medications affect different aspects of lipoprotein metabolism...
  27. ncbi Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia
    K G Parhofer
    II Medizinische Klinik, Ludwig Maximilians Universitat, Munchen, Germany
    Horm Metab Res 22:589-94. 1990
    ..We therefore conclude that type II diabetes mellitus is a possible cofactor in the apolipoprotein-E2 associated hyperlipoproteinemia...
  28. ncbi Lipid apheresis: the only therapeutic option for a very small group of cardiovascular patients with high low-density lipoprotein cholesterol or lipopoprotein(a) blood concentrations
    Peter Schwandt
    Ther Apher Dial 7:283-4. 2003